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Abstract
Adenovirus vectors are capable of high efficiency in vivo
arterial gene transfer, and are currently in use as therapeu-
tic agents in animal models of vascular disease. However,
despite substantial data on the ability of viruses to cause
vascular inflammation and proliferation, and the presence
in current adenovirus vectors of viral open reading frames
that are translated in vivo, no study has examined the effect
of adenovirus vectors alone on the arterial phenotype. In a
rabbitmodel ofgene transfer into anormal artery, we exam-
ined potential vascular cell activation, inflammation, and
neointimal proliferation resulting from exposure to replica-
tion-defective adenovirus.
Exposure of normal arteries to adenovirus vectors re-
sulted in: (a) pronounced infiltration of T cells throughout
the artery wall; (b) upregulation of intercellular adhesion
molecule-i and vascular cell adhesion molecule-i in arterial
smooth muscle cells; (c) neointimal hyperplasia. These find-
ings were present both 10 and 30 d after gene transfer, with
no evidence of a decline in severity over time.
Adenovirus vectors have pleiotropic effects on the arte-
rial wall and cause significant pathology. Interpretation of
experimental protocols that use adenovirus vectors to ad-
dress either biological or therapeutic issues should take
these observations into account. These observations should
also prompt the design of more inert gene transfer vectors.
(J. Clin. Invest. 1995. 96:2955-2965.) Key words: adenovi-
ruses * arteries * gene transfer * inflammation * rabbits
Introduction
In vivo gene transfer into the arterial wall is a powerful experi-
mental approach by which one may both investigate the function
of individual genes in the development of arterial pathology
(1) and attempt to manipulate the arterial wall for therapeutic
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purposes (2-5). Recently, replication-defective adenovirus has
become the arterial gene transfervector-of-choice for amajority
of investigators (6-11). The advantages of adenovirus as an
arterial gene transfer vector include the ease of preparation of
high-titer virus (> 1010 plaque forming units [pful' per ml)
(12), and the ability of adenovirus to infect nondividing cells
with high efficiency (13), including the endothelial cells and
smooth muscle cells (SMC) ofthe arterial wall (6, 7, 9, 14). A
potential disadvantage ofadenovirus as an arterial gene transfer
vector is that, despite the El gene deletion that renders the virus
defective for replication, the remaining virus genome contains
numerous open reading frames encoding viral proteins (12).
Expression of viral proteins by transduced cells elicits both
humoral and cellular immune responses in animals (15-18)
and could conceivably provoke arterial cell activation, inflam-
mation, and proliferation, as has been reported for wild-type
viruses (19).
Despite the potential foradenovirus vectors to produce dele-
terious effects on the arterial wall, no study has yet examined
the effects of these vectors on the arterial phenotype. Primary
effects of adenovirus vectors (i.e., effects unrelated to any in-
serted transgene) would be a major concern in the design of
biological experiments and could also confound the design and
interpretation of therapeutic experiments. For example, in arte-
rial gene transfer experiments with a therapeutic endpoint (2-
4), it is generally perceived that the adenovirus acts as an inert
carrier of a therapeutic gene, and that the achievement of a
beneficial endpoint is neither moderated nor prevented by inde-
pendent effects of the vector. Certainly, widely held current
views of adenovirus vectors do not envisage the possibility that
they could have primarily detrimental effects on the arterial
wall (20, 21).
In this study, we investigated the effects of adenovirus-
mediated gene transfer per se on arterial cell activation, mono-
nuclear leukocyte infiltration, and intimal proliferation. To ac-
complish this objective, we infused adenovirus or control solu-
tions into surgically isolated, normal rabbit femoral arteries.
The arteries were harvested at time points up to 30 d after
virus infusion and assayed for: (a) expression of intercellular
adhesion molecule-i (ICAM-1), vascular cell adhesion mole-
cule-I (VCAM-1), and MHC-H antigens (all markers ofvascu-
lar cell activation [22, 23]); (b) presence of inflammatory T
1. Abbreviations used in this paper: /3-Gal, /3-galactosidase; ICAM-1,
intercellular adhesion molecule-1; pfu, plaque forming unit; SMC,
smooth muscle cell; VCAM-1, vascular cell adhesion molecule-l; X-
Gal, 5-bromo-4-chloro-3-indolyl-,/-D-galactopyranoside.
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Methods
Adenovirus vectors. We used two adenovirus vectors: AvlLacZ4 and
AvlNul2. Both vectors were provided by Dr. Bruce Trapnell (Genetic
Therapy Incorporated, Gaithersburg, MD). The construction of Avl-
LacZ4, a replication-defective adenovirus containing a nuclear-targeted
Escherichia coli ,/-galactosidase (j3-Gal) transgene, has been described
(7). AvlNul2 is also a replication-defective El/E3-deleted adenovirus
that is essentially identical to AvlLacZ4, except that the genome of
Av1Nul2 does not contain a nuclear-targeted ,3-Gal expression cassette.
We used the latter vector as a control to elucidate whether effects
observed with AvlLacZ4 were due to exposure to replication-defective
adenovirus or to the /3-Gal transgene. Viral stocks were generated by
infection of 293 cells and were concentrated by two rounds of cesium
chloride ultracentrifugation (12). Cesium-banded virus stocks were dia-
lyzed against 10 mM Tris pH 7.4, 1 mM MgCl2, and 10% glycerol;
they were then aliquotted, and stored over liquid nitrogen until use. The
concentrations of stocks of AvlLacZ4 and Av1Nu12 were 2 X 1011 and
8 x 1010 pfu/ml, respectively, as determined by plaque titration on 293
cells.
For animal experiments, frozen vector stocks were thawed and used
within 30 min. AvlLacZ4 stock was diluted 1:10 to a final concentration
of 2 x 1010 pfu/ml in DME (Biofluids Inc., Rockville, MD) containing
1 mg/ml rabbit serum albumin (Sigma Chemical Co., St. Louis, MO).
Av1Nu12 stock was diluted 1:4 to achieve the same final concentration
of 2 x 1010 pfu/ml. We infused control vessels with two types of
nonvirus-containing solution: (a) the "viral diluent" (DME with 1 mg/
ml rabbit albumin); (b) the "virus storage buffer" (10 mM Tris pH
7.4, 1 mM MgCl2, 10% glycerol) diluted either 1:10 or 1:4 with viral
diluent, to match the concentration of virus storage buffer in the diluted
adenovirus preparations.
Animalsurgery. All animalprocedures were approvedbytheAnimal
Care and Use Committee ofthe National Heart, Lung, and Blood Insti-
tute. Adult New Zealand White rabbits (Hazleton Research Products,
Inc., Denver, PA), weighing 3-5 kg, were used. Anesthesia was induced
with ketamine (Fort Dodge Laboratories Inc., Fort Dodge, IA) 8 mg/
kg intravenously and xylazine (Miles Inc., Shawnee Mission, KS) 3
mg/kg intramuscularly. After endotracheal intubation, glycopyrrolate
0.1-0.2 mg (Fort Dodge Laboratories, Fort Dodge, IA) was adminis-
tered intramuscularly and anesthesia was maintained with inhaled
isoflurane 1-2% (Ohmeda, Madison, WI). Enrofloxacin 2.27% (0.2
cm3/kg) was injected subcutaneously b.i.d. for 3 d for infection prophy-
laxis. A total of 59 rabbits received adenovirus infusion in one femoral
artery and a control infusion in the contralateral femoral artery. Two
rabbits received bilateral femoral artery infusions of UV-inactivated
adenovirus (see below). One additional rabbit underwent balloon injury
ofthe iliac artery to provide apositive control forimmunohistochemistry
experiments, and two rabbits underwent bilateral femoral infusion of
control solutions, with pressure monitoring (see below). These latter
three rabbits received no virus infusion.
Vascular surgery was performed with the aid of a Zeiss Universal
S3 operating microscope (Oberkobern, Germany) at 2-10 times magni-
fication (Fig. 1). Both superficial femoral arteries were exposed and
isolated circumferentially from the inguinal ligament to the knee; all
side branches were ligated. Topical lidocaine 1% (Abbott Laboratories,
North Chicago, IL) was applied to each artery as needed (typically
twice) to relieve spasm. Rabbits were given 100 U/kg of intravenous
heparin (Elkins-Sinn, Inc., Cherry Hill, NJ). To obtain an isolated arte-
rial segment for gene transfer, the superficial femoral artery was first
controlled proximally with two microvascular clips. A needle hole was
created between the two clips with a 27-gauge needle to provide a site
of egress for infused solutions. The popliteal artery was then occluded
with a microvascular clip and distal control of the saphenous artery at
the knee was obtained with a silk tie and a microvascular clip. An
Figure 1. Surgical protocol for isolation of rabbit femoral arteries and
infusion of adenovirus. With the rabbit in the supine position (right),
each superficial femoral artery is isolated between surgical clips. The
infusion catheter, attached to a syringe (not to scale), is shown in the
saphenous artery and is secured with a tie. The needle hole (arrow)
between the proximal clips permits flushing of the vessel lumen and
infusion of the virus, without leakage or mixture with arterial blood,
and with minimal vessel collapse.
arteriotomy was made between the tie and the clip and a Silastic catheter
(0.012 inches inner diameter, 0.025 inches outer diameter; Reed Plas-
tics, Rockville, MD) was introduced into the lumen. The isolated vessel
was flushed via the catheterwith
- 0.2-0.5 ml ofthe appropriate control
solution, removing all blood from within the vessel lumen via the proxi-
mal needle hole. Care was taken to avoid vessel collapse or introduction
of air that could result in endothelial injury. The catheter was then
withdrawn and replaced with another catheter prefilled with either the
experimental virus or a control solution. All solutions were infused so
as to flush the medium through the needle hole, followed by reapplica-
tion of the proximal femoral clip to occlude the segment and continued
infusion of a volume of solution adequate to distend the vessel slightly.
Approximately 200 Il of infusate was required to accomplish flushing,
filling, and distension of the artery. The infused solutions were allowed
to dwell in situ for 20 min. At the conclusion of this incubation, the
proximal needle hole was repaired with a single 10-0 suture (Ethicon,
Somerville, NJ). The catheter was removed and the saphenous artery
was ligated. Flow was reestablished by removing the clips on the proxi-
mal superficial femoral and deep popliteal arteries. The wounds were
closed, and animals recovered from anesthesia. In two additional ani-
mals, we measured the infusion pressure during bilateral infusion of
control solutions by using a pressure transducer connected to the infu-
sion catheter. Intraluminal pressure was monitored with a physiologic
recorder (Gould Electronics, College Park, MD). The infusion pressure
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4-varied between 80 and 100 mmHg during the 20-min infusions in all
four vessels that were tested.
To obtain a positive control vessel for use in immunohistochemical
experiments, we performed balloon injury of the iliac artery in one
rabbit (22). 5 d later, this animal was injected intravenously with Evans
Blue dye. The animal was then killed, the iliac artery harvested, and
the area of injury identified as the segment with Evans Blue staining.
The blue-stained segment was excised, snap-frozen, and processed as
described below for immunohistochemical analysis.
To begin to investigate the species potential specificity of our find-
ings in this rabbit model, we also examined sections from uninjured rat
carotid arteries transduced with AvlLacZ4 at 3 X 1010 pfu/ml and
harvested 14 (n = 4) (24) and 28 d (n = 5) after gene transfer.
These sections were examined both for neointima formation and for the
presence of T cells, using techniques described elsewhere (24, 25).
Harvesting of vessels. Vessels were harvested at 3, 10, and 30 d
after gene transfer. Vessels were either perfusion-fixed in situ or were
snap-frozen for immunohistochemical analysis. Perfusion fixation was
carried out as follows: general anesthesia was achieved, the abdominal
aorta was exposed through a midline incision, and 100 U/kg ofheparin
were given intravenously. The aortawas ligated, and a 19-gauge catheter
introduced distal to the ligation. A venotomy was made in the inferior
vena cava. 500 ml of Ringer's Lactate were infused into the distal
abdominal aorta until the caval effluent was clear. The animal was
then killed by intravenous overdose of potassium chloride. For vessels
undergoing histochemical staining for/i-Gal, 1,500 ml of2% formalde-
hyde (Mallinckrodt, Paris, KY), 0.2% glutaraldehyde (Sigma Chemical
Co.) in PBS was perfused at 80 mmHg via the distal aorta. For vessels
undergoing histologic analysis of intimal/medial area ratios, 1,000 ml
of 10% formaldehyde in PBS was perfused at 80 mmHg through the
distal aorta. After the perfusion fixation, a 1.5-cm segment of each
common femoral artery was excised, and incubated further for 2 h in
the appropriate fixative.
Arterial samples for frozen sections were obtained as follows: gen-
eral anesthesia was achieved and the common femoral arteries and
abdominal aorta were exposed. The animal was injected intravenously
with 100 U/kg heparin and killed with an intravenous overdose of
potassium chloride. Segments of the abdominal aorta and of each com-
mon femoral artery, all approximately 1 cm in length, were harvested
and rinsed with Ringer's Lactate. The segments were then embedded
by immersion in optimal cutting temperature compound (Tissue Tek H;
Miles Laboratories, Elkhart, IN) followed by freezing in isopentane.
Frozen sections (6-pm thickness) were cut on a cryostat, air-dried, and
stored at -80'C until used in immunohistochemical studies.
Histochemical staining for /8-Gal expression. 16 rabbits were in-
fused with AvlLacZ4 on one side and viral diluent on the contralateral
side. Vessels were harvested at 3 (n = 5), 10 (n = 4), and 30 d (n
= 7). The arterial segments were washed in PBS and incubated in 5-
bromo4-chloro-3-indolyl-,/-D-galactopyranoside (X-Gal) for 2 h at
3°C. The vessel segments were then washed in PBS, cut longitudinally,
and examined for evidence of /3-Gal expression. These stained vessel
segments were each divided into three segments of - 3-mm length and
embedded in paraffin. Three cross sections (5-Mm thick and spaced at
least 50 pm apart) were cut from each segment and counterstained with
nuclear fast red (nine sections per vessel). These sections were exam-
ined with light microscopy, and the numbers ofX-Gal-stained luminal
endothelial cells, X-Gal-stained medial SMC, and total luminal endo-
thelial cells (both stained and unstained) were counted. From these
data, we calculated percentages of luminal endothelial cells that were
transduced, as well as the percentages oftotal transduced cells that were
endothelial cells for each vessel. The media of these normal rabbit
femoral arteries, harvested 3 d after gene transfer, were identified as
containing essentially only SMC by staining of frozen sections with an
antibody to SMC actin (26) (data not shown). Luminal cells were
identified as endothelial cells by morphology (flattened with prominent
nuclei) and by luminal location.
/3-Gal expression was also detected in frozen sections by fixation
of sections with 2% formaldehyde, 0.2% glutaraldehyde for 5 min fol-
lowed by a rinse with PBS and exposure of fixed sections to X-Gal
staining solution for 60 min at 370C.
Immunohistochemistry. One group of rabbits (n = 11) was infused
with AvlLacZ4 on one side and virus diluent on the contralateral side.
Vessels were harvested at 3 (n = 4), 10 (n = 4), and 30 d (n = 3).
Because of a concern that the viral diluent alone might not be the most
suitable control for the diluted viral stocks, a second group of rabbits
(n = 4) was infused with AvlLacZ4 in one femoral artery and diluted
virus storage buffer (see above) on the contralateral side. Vessels from
this group of rabbits were harvested at 30 d. To control for effects
attributable to the /3-Gal transgene, a third group of rabbits (n = 4)
was infused with AvlNul2 in one femoral artery and with diluted virus
storage buffer on the contralateral side. Vessels in this group of rabbits
were harvested at 30 d.
To obtain vessel cross sections for immunohistochemistry, serial
cryostat sections were cut from each block. The block for each rabbit
contained sections of aorta (unmanipulated), of the femoral artery ex-
posed to adenovirus, and of the femoral artery exposed to the control
solution. The sections were air-dried, fixed in acetone at -20'C for 5
min, incubated with PBS containing 0.3% hydrogen peroxide to reduce
endogenous peroxidase activity, preincubated with 5% normal horse
serum to prevent nonspecific binding of antibodies, and then incubated
with primary antibodies diluted in 10% horse serum (Vector Labora-
tories, Burlingame, CA) at room temperature for 90 min. After washing
with Tris-buffered saline (0.05 M Tris, pH 7.6) containing 2% horse
serum, species-appropriate biotinylated secondary antibodies were ap-
plied followed by avidin-biotin peroxidase complex (Vectastain ABC
Elite kit; Vector Laboratories). Antibody binding was visualized with
3-amino-9-ethyl carbazole (Vector Laboratories). Sections were coun-
terstained with hematoxylin. Omission of primary antibodies served as
a negative control for each antibody. Positive control sections (taken
from the balloon-injured rabbit iliac artery) were also tested.
Immunohistochemical staining was performed with a series of five
monoclonal antibodies: mAb Rbl/9 (recognizing rabbit VCAM-1);
mAb Rb2/3 (recognizing rabbit ICAM-1); mAb RAM-l1 recognizes
a cytoplasmic antigen protein expressed by rabbit alveolar macrophages
(Dako Corp., Carpinteria, CA); mAb 2C4 binds to a framework deter-
minant of the alpha chain of a rabbit MHC-ll antigen (RLA-DR); and
mAb L- 1 /135 detects a 120-kD glycoprotein determinant present on
rabbit thymocytes and peripheral T cells (27). Each antibody was ap-
plied to three histologic sections selected at random from along the
length ofeach artery. The sections were evaluated with light microscopy
and graded for primary antibody reactivity by two independent observ-
ers, each of whom was blinded to the identity ofthe sections. Antibody
reactivity on each section was scored with the aid of a semiquantitative
scale of 0 to 4 in which: 0 = no staining; 1 = staining barely visible
at low (x 100) power; 2 = diffuse faint or focal staining clearly visible
at low power; 3 = moderate intensity with multifocal staining; 4
= intense, diffuse staining. The scores of the 2 observers were highly
correlated (r2 = 0.96; P < 0.0001). For convenience, therefore, scores
from only one observer were used for calculation ofvessel mean scores.
To permit a nonparametric statistical analysis of data that was not ex-
pected to be normally distributed, all of the vessels harvested at each
time point and stained with a given antibody were also ranked in order
of the intensity of staining.
Infusion of UV-inactivated adenovirus. To test the hypothesis that
improvements in adenovirus vector design that decrease viral gene ex-
pression will also decrease the level of vascular cell activation after
arterial gene transfer, we infused UV-inactivated AvlLacZ4 into four
femoral arteries in two rabbits. Before infusion, aliquots of AvlLacZ4
were exposed to 260 nm UV light at a distance of 1 cm for 200 s. This
treatment was confirmed to result in a significant decrease in virus gene
expression after infection of cells in vitro with relative preservation of
virus protein function in vitro as measured by ability of the UV-inacti-
vated virus to enhance the efficiency of plasmid cotransfection (28)
(data not shown). Aliquots of UV-inactivated AvlLacZ4 used for in
vivo experiments were of the same "prep'" as was used for the experi-
ments with non-UV-inactivated virus.
Vascular Activation After Adenovirus Gene Transfer 2957Figure 2. Histological localization of transduced femoral arterial cells. Photomicrographs A-C are of sections harvested 3 d after infusion of
AvlLacZ4, stained with X-Gal, and counterstained with nuclearfastred. (A) Low powerview shows recombinant gene expression in both endothelial
and medial SMC. (B) High power view ofarea ofefficient, endothelial-specific gene transfer. (C) High power view of area ofdenuded endothelium
and focal medial SMC gene transfer. Three cells in the adventitia also express the recombinant gene. (D) Section from an artery harvested 10 d
after infusion with AvlLacZ4, also stained with X-Gal and nuclear fast red. A neointima is present above the internal elastic lamina (arrows).
Several medial SMC stain positively with X-Gal. Original magnifications: 25 (A); 100 (B-D).
Vesselmorphometry. 12 rabbits were infused withAvlLacZ4 on one
side and viral diluent on the contralateral side. Vessels were harvested at
10 (n = 6) and 30 d (n = 6). A second group of rabbits (n = 7) was
infused with AvlLacZ4 on one side and virus storage buffer (diluted
1:10 with virus diluent) on the contralateral side. This group of rabbits
underwent vessel harvest only at 30 d. A third group of rabbits (n
= 5) was infused with AvlNu12 on one side and virus storage buffer
(diluted 1:4 with virus diluent) on the contralateral side. Vessel harvest
for this third group was again performed at 30 d only.
To obtain sections for morphometric analysis, the perfusion-fixed
vessels were divided into segments of 2-mm length and embedded in
paraffin. Cross sections (5-pm thick) were cut from each segment and
stained with Movat's pentachrome stain. Computerized morphometric
measurements of intimal area, medial area, and intimal/medial area
ratio were made using a computerized morphometric imaging system
(IPLab' Image Analysis Software, Version 2.5, Vienna, VA) using
an Olympus BH2 microscope at 40x and Sony 3CCD color video
camera. Four randomly-chosen histologic sections from each vessel
were analyzed and used to calculate a mean intimal/medial area ratio
for each vessel.
Statistics. Mean intimal/medial area ratios for groups ofexperimen-
tal and control vessels were compared using a two-tailed unpaired Stu-
dent's ttest. Ranked staining intensities assigned from the immunohisto-
chemical studies were compared by nonparametric analysis. A Mann-
Whitney U statistic (29) was calculated to examine the null hypotheses
(using a two-tailed a of 0.05) that: (a) the adenovirus-exposed vessels
had the same degree of staining as the control vessels; and (b) the
vessels infused with UV-inactivated adenovirus had the same degree of
staining as vessels infused with non-UV-inactivated virus. Data are
presented as mean ±SD.
Results
Vessel patency, distribution, and duration ofrecombinant gene
expression after infusion ofAvlLacZ4. All vessels harvested 3
d after gene transfer were patent. On both gross andmicroscopic
examination, five of five experimental arteries stained for re-
combinant P-Gal. As expected, none of the control arteries
stained positively. /3-Gal activity was detected primarily in lu-
minal endothelial cells and in medial SMC (Fig. 2, A-C). A
small number of transduced cells were seen in the adventitia
(Fig. 2 C). The total number oftransduced luminal endothelial
cells per histologic cross section of AvlLacZ4-infused arteries
was 37.3±11.5. The total number of luminal endothelial cells
was 103±22.1, and the overall percentage of the total luminal
endothelial cells that had been transduced was 36±6%. The
number of transduced SMC per histologic section was 11.4±6,
representing 25±28% oftotal transduced cells, with the remain-
der (75+±29%) identified as endothelial. A small amount of
endothelial denudation was observed in both control and Avl-
LacZ4-transduced vessels, and this finding was correlated with
the presence of subjacent transduced SMC. This animal model
is therefore one of high efficiency, predominantly endothelial
gene transfer into a minimally injured peripheral artery.
All vessels harvested 10 d after gene transfer were patent.
On gross examination, neither experimental nor paired control
arteries (n = 4) stained positively for recombinant gene expres-
sion. On microscopic examination, four of four experimental
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Figure 3. Increased expression of ICAM-1, VCAM-1, and increased T cell infiltration in rabbit femoral arteries 10 d after exposure to AvlLacZ4.
Staining is for ICAM-1 (A-C); VCAM-1 (D-F); T cells (G-I). Infusates are indicated at top; virus-infused vessels were all infused with
AvlLacZ4 (A, B, D, E, G, and H). Control vessels were infused with virus diluent (C, F, and I). Original magnifications: 25 (A, C, D, F, G, and
I); 100 (B, E, and H).
vessels and zero of four controls contained cells staining posi-
tively for nuclear-localized P-Gal. The number of transduced
endothelial cells per histologic section was 1.8±0.6, and the
number of transduced SMC per section was 8±1.7 (Fig. 2 D).
Six of seven vessels exposed to AvlLacZ4 and harvested
30 d after gene transfer were patent; seven of seven matched
control vessels were patent. On gross examination, there was
noevidence ofrecombinant gene expression in eithertheexperi-
mental or the control vessels. On microscopic examination,
there were rare transduced medial SMC in the experimental
vessels. There were no transduced intimal cells in the experi-
mental vessels, and no transduced cells at all in the control
vessels. Thus, in agreementwithprevious reports ofadenovirus-
mediated gene transfer into the arteries of adult animals (6, 7,
9, 11), recombinant gene expression in this animal model was
transient and was essentially undetectable by 4 wk.
Vascular cell activation and inflammation after exposure to
adenovirus. To test the hypothesis that adenovirus-mediated
gene transfer results in inflammation and activation ofthe cells
of the arterial wall, we performed immunohistochemical stain-
ing for ICAM-1, VCAM-1, MHC-II, macrophages, and T cells
on frozen sections of arteries harvested 3, 10, and 30 d after
genetransfer(Figs. 3,4, anddatanotshown). Ourinitial exami-
nation of 3-d sections revealed considerably less positive stain-
ing than in 10- and 30-d sections; therefore, our analyses were
confined to the 10- and 30-d sections. At 10 d, intense areas of
positive staining for ICAM-1, VCAM-1, and T cells were pres-
ent in both the neointima and the media ofvessels infused with
AvlLacZ4 (Fig. 3). Staining intensities were approximately
equal in the media and developing neointima. Semiquantitative
analysis of sections from both experimental and control vessels
revealed significantly increased staining for all three of these
markers of vascular activation (Fig. 5 A; P < 0.05 for each;
Mann-Whitney U test). The mean score for ICAM-1 was
2.7±1.2 in the experimental vessels and 0.56±0.51 in the con-
trols. Intensity ofVCAM-1 staining was 2.3±0.87 in the experi-
mentals and was not detectable in sections from control vessels
(zero for all sections). Because ICAM-1 and VCAM-1 staining
was largely confined to the media and neointima, and because
macrophages were rare in all sections (typically zero or one
macrophage per section), we presume that ICAM-1 and
VCAM-1 expression was primarily from vascular SMC.
We also stained frozen sections for the presence of T cells,
macrophages, and MHC-II. The intensity ofT cell staining was
graded as 3.1±0.84 in vector-infused vessels, and 0.44±0.77
in the controls. There was also a small, statistically insignificant
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Figure 4. Increased expression of ICAM-1, VCAM-1, and increased T cell infiltration in rabbit femoral arteries 30 d after exposure to adenovirus.
Staining is for ICAM-1 (A-C); VCAM-1 (D-F); T cells (G-I). Infusates are indicated at top; virus-infused vessels were infused with AvlLacZ4
(G and H) or AvlNul2 (A, B, D, and E). Control vessels were infused with virus diluent (C, F, and I). Original magnifications: 25 (A, C, D, F,
G, and I); 100 (B, E, and H).
increase in staining for macrophages in experimental versus
control vessels (0.78±1.3 vs 0). The intensity of staining for
MHC-II expression did not differ between experimental and
control vessels (2.0±0.89 vs 2.3±1.4). Control sections taken
from nonmanipulated segments of abdominal aorta (stained in
parallel with the experimental and control femoral arteries) did
not have detectable staining for any of the five markers (not
shown).
Immunohistochemical staining for inflammatory cells and
for markers of vascular activation was repeated with sections
taken from femoral arteries harvested 30 d after infusion of
either AvlLacZ4 or either of the two control solutions (see
Methods). Similar to the findings at 10 d, staining for ICAM-
1, VCAM-1, andT cells was strongly positive in theAvlLacZ4-
infused arteries. At 30 d, staining was present predominantly
in the media rather than the neointima and was most often focal
rather than diffuse (for example, Fig. 3 D and Fig. 4A). There
was minimal staining in the control vessels. Semiquantitative
analysis of stained sections revealed that ICAM-1, VCAM-1,
and T cell immunoreactivity were significantly increased in
AvlLacZ4-infused arteries (Fig. 5 B; P < 0.05 for each of the
three markers; Mann-Whitney Utest). Mean staining intensities
for experimental and control vessels were: ICAM-1, 2.5±1.0
vs 0.24±0.34; VCAM-1, 1.8±1.0 vs 0; T cells, 2.8±1.2 vs 0).
Again, similar to the findings at 10 d, there was a slight (but
not statistically significant) increase in histochemical staining
for macrophages in experimental vessels (0.58±0.73 vs 0 in
controls). In contrast to the 10-d findings, MHC-II expression
was significantly increased in AvlLacZ4-transduced vessels
(3.0±0.6 vs 1.6+0.4; P < 0.05; Mann-Whitney U test).
The immunohistochemical study was repeated at the 30-d
time point using AvlNul2. Femoral arteries infused with Avl-
Nu12 and harvested at 30 d stained prominently for ICAM-1,
VCAM-1, and T cells (Fig. 4, and data not shown). Semiquanti-
tative analysis of histologic sections taken from AvlNul2 and
control-infused vessels revealed significant increases in staining
for ICAM-1, VCAM-1, and T cells (Fig. 5 C; P < 0.05 for
each comparison; Mann-Whitney U test). Mean scores from
experimental and control vessels were: ICAM-1, 2.5±1.8 vs
0.42±0.84; VCAM-1, 2.3+1.8 vs 0; and T cells, 3.2±1.0 vs
0.12±0.14. AvlNul2-infused vessels had levels ofstaining that
were slightly increased above those of control-infused vessels
forboth macrophages (0.33±+0.47 vs 0) and MHC-II expression
(1.7+1.5 vs 1.1±0.92); these differences were not statistically
2960 Newman et al.Figure 5. Intensity of
histochemical staining
for detection of ICAM-1
expression, VCAM-l ex-
pression, T cell infiltra-
tion, macrophage infil-
tration, and MHC-HI ex-
pression. See Methods
fordescription of0-4 in-
tensity scale. (A) Vessels
harvested 10 d after infu-
sion of either AvlLacZ4
or control solution (n =
4 vessels for each
group). (B) Vessels har-
vested 30 d afterinfusion
of either AvlLacZ4 or
control solutions (n = 7
vessels for each group).
(C) Vessels harvested 30
d after infusion of either
AvlNul2 or control so-
lution (n = 4 vessels for
each group). The heights
of the bars represent
mean values calculated
from the values ofthe in-
dividual vessels in each
group; error bars indicate
standard deviations.
Mean values of 0 are
shown asbars ofminimal
height, without error
bars.
significant. Sections taken from nonmanipulated segments of
abdominal aorta were again included as controls. As was found
in the rabbits infused with AvlLacZ4, there was no detectable
staining of sections from uninjured aortas with any of the five
antibodies (not shown).
To determine whether ICAM-l and VCAM-l were upregu-
lated only in adenovirus-infected cells, serial frozen sections
were taken from three arteries harvested 10 d aftergene transfer.
These serial sections were stained for 1-Gal expression as well
as for ICAM-1, VCAM-1, and T cells (Fig. 6). Expression of
ICAM-1 and VCAM-I was not limited to cells that stained blue
with X-Gal. ICAM-1- and VCAM-1-expressing cells were
distributed both in the vicinity of transduced cells as well as in
other areas of the artery. Staining for T cells revealed that
ICAM-l and VCAM-1 expression colocalized far more closely
with T cells than with the ,1-Gal-expressing cells.
Infusion ofUV-inactivated virus. Four arteries infused with
UV-inactivated AvlLacZ4 were harvested at 10 d. Frozen sec-
tions (three per vessel for each stain) were either stained for
P-Gal expression with X-Gal, or immunostained for ICAM-1,
VCAM-1, and T cells. There was no ,1-Gal expression in any
of the vessels, consistent with UV inactivation of vector gene
expression. Sections stained for ICAM-1, VCAM-1, and T cells
were graded for staining intensity, as described above. A mean
staining score for each vessel was determined, and this score
was used to rank all four vessels for staining intensity along
with sections for four arteries that were infused with non-UV-
inactivated virus and also harvested at 10 d. The mean intensi-
ties of staining for ICAM-1, VCAM-1, and T cells in arteries
infused with UV-inactivated virus were: 1.8±0.50, 0.75±0.96,
and 1.5±0.58, whereas the mean intensities in arteries infused
with non-UV-inactivated virus were 3.0±1.1, 2.5±0.58, and
3.5±0.58. Statistical analysis revealed that each of these three
markers of vascular activation was significantly less prominent
in arteries infused with UV-inactivated virus (P < .05, Mann-
Whitney U test).
Measurement of intimal/medial area ratios in vessels ex-
posed to adenovirus. As an additional measure ofthe effects of
adenovirus on the activation of the arterial wall, we examined
perfusion-fixed arteries harvested both at 10 and 30 d for the
presence of a neointima (Figs. 7 and 8). The presence of a
neointima was far more common in virus-infused than in con-
trol-infused arteries (compare Fig. 7 A and B to Fig. 7 C and
D). To test for thepresence ofsignificantdifferences in intimal/
medial area ratios, quantitative analysis was performed of the
intimal and medial areas of arteries infused with AvlLacZ4,
AvlNul2, or control solutions (Fig. 8). In arteries harvested at
10 d, the mean intimal/medial area ratio in the AvlLacZ4-
exposed vessels was increased by fivefold compared to the con-
trol vessels (0.20±0.19 vs 0.037±0.08); however, this differ-
ence fell short of statistical significance (P = 0.08; Student's t
test; Fig. 7). In vessels harvested at 30 d, the mean intimal/
medial area ratio for all AvlLacZ4-exposed vessels (n = 13)
was increased fourfold over those in the pooled control groups
(n = 13): 0.64±0.35 vs 0.15±0.17, P < 0.008. If the two
control groups were compared separately, significant 3-10-fold
differences were still found: 0.7±0.43 vs 0.06±0.02, P < 0.005
for the virus diluent controls (n = 6); 0.59±0.3 vs 0.24±0.20,
P = 0.02 for the diluted virus storage buffer controls (n = 7).
To determine whether the observed effect of AvlLacZ4 on
neointima formation was due to the virus or to the 13-Gal
transgene, an additional group of four rabbits was infused with
AvlNul2 and appropriately diluted virus storage buffer. All
vessels were harvested 30 d after gene transfer. The mean inti-
mal/medial area ratio for the AvlNul2-infused vessels was in-
creased by 10-fold over that of vessels infused with control
solution (0.67±0.12 vs 0.063±0.06; P < 0.005; Student's t
test). Thus, exposure to adenovirus resulted in the observed
neointimal hyperplasia.
Inflammation and neointima formation in transduced rat
arteries. In uninjured rat carotid arteries transduced with Avl-
LacZ4, there was very little neointima present at both 14 and
28 d; intimal/medial area ratios were 0.1 and below (data not
shown; compare to Fig. 8). Also in contrast to the findings with
rabbit arteries, there was no medial T cell infiltrate present in
any of the rat arteries. Rare T cells were seen on the luminal
surface of the artery, in the neointima, and in the adventitia:
zero to three cells per section (not shown; compare Fig. 3, G
and H and Fig. 4, G and H). We did not stain for ICAM-l and
VCAM-1 expression due to a lack of specific antisera directed
against the rat proteins. Thus our findings of infiltration and
intimal hyperplasia consequent to adenovirus gene transfer may
have a degree of species specificity.
Discussion
The major findings of this study are that adenovirus-mediated
gene transfer into surgically exposed normal rabbit femoral ar-
teries results in: (a) efficient, relatively endothelial-specific
gene transfer with transient (essentially < 10 d) recombinant
gene expression; (b) prolonged (2 30 days) activation of vas-
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cular SMC, as manifested by increased expression of the adhe-
sion molecules ICAM-1 and VCAM-1; (c) prolonged (2 30
days) T cell infiltration into the media and neointima; and (d)
significantly increased neointima formation.
Weusedrabbit arteries to attempt to delineatepossible detri-
mental effects of replication-defective adenovirus vectors on
the arterial wall. The rabbit was chosen because ofits utility as
an animal model ofvascular disease (30). It is likely that future
studies using adenovirus-mediated gene transfer both to study
and to treat vascular disease will be carried out in rabbits (8,
11); therefore, a study defining the baseline effects of adenovi-
rus vectors in this species is appropriate. We used "normal"
rabbit arteries, not subjected to intentional injury, for two rea-
sons: (a) to minimize animal-to-animal variability and (b) to
increase the sensitivity of our assays to detect the three experi-
mental endpoints of vascular cell activation, inflammation, and
neointima formation by looking for these features in normal
arteries, in which they are not usually present. We did not
extend this study to diseased arteries because expected high
background levels of vascular activation (22, 31, 32) and re-
cently reported low gene transfer efficiency (33) render studies
in diseased arteries problematic.
Infusion ofreplication-defective adenovirus (with and with-
out an inserted ,6-Gal transgene) resulted in enhanced vascular
SMC expression of ICAM-1 and VCAM-1. While the precise
roles of these adhesion molecules in the vessel wall are not yet
clear (23), vascular expression of ICAM-1 and VCAM-1 is
strongly associated with arterial pathology in both animals and
humans. When expressed by vascular endothelium, ICAM-1
and VCAM-1 are believed to participate in the adhesion and
consequent entry of mononuclear leukocytes into the arterial
wall (34). In experimental atherosclerosis in rabbits, increases
in endothelial VCAM-1 expression are among the earliest vas-
cular changes, preceding monocyte infiltration (31, 32). In-
creased SMC expression ofICAM-1 and VCAM-1 is also asso-
ciated with both established and evolving vascular disease,
though the precise role of SMC adhesion molecule expression
is less well understood. In balloon-injured rabbit aortas, both
ICAM-1 and VCAM-1 are upregulated in SMC (22). Enhanced
expression of both ICAM-1 and VCAM-1 has also been re-
ported in SMC within human atherosclerotic lesions (35-37).
Thus, in both rabbit and human studies, ICAM-1 and VCAM-
1 are viewed as either markers of, or actual participants in, the
development of arterial pathology.
In view of their association with arterial disease, the pro-
longed and prominent expression of ICAM-1 and VCAM-1
after exposure of normal rabbit arteries to adenovirus has im-
portant implications for those who use adenovirus as a tool
for treating or understanding vascular disease. For example,
experiments attempting adenovirus-mediated overproduction of
soluble VCAM-1 as a therapeutic strategy (38) might be con-
founded by enhancedproduction ofendogenous, cell-associated
VCAM-1. In a hypothetical experiment in which arterial infu-
sion of an adenovirus vector expressing monocyte chemotactic
protein-i results in monocyte infiltration, a conclusion that
monocyte chemotactic protein-i is uniquely responsible for this
finding might notbejustified. A directcontribution ofthe vector
itselfto monocyte infiltration, through upregulation ofadhesion
2962 Newman et al.Figure 7. Neointima formation in rabbit femoral arteries infused with adenovirus. (A and B) Low and high power views of artery infused with
control solution. (C and D) Low and high power views of artery infused with AvlLacZ4. Demarcation of the internal elastic lamina (indicated
with arrows in B and D) reveals the presence of a significant neointima in the AvlLacZ4-infused vessel. All panels: Movat's pentachrome stain.
Original magnifications: A and C, X25; B and D, xO00.
molecules, would require consideration and specific experimen-
tal evaluation.
The route by which exposure to adenovirus results in upreg-
ulation of SMC ICAM-1 and VCAM-1 is not clear; however,
P < 0.008
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Figure 8. Intimal/medial (IIM) ratios in arteries exposed to AvlLacZ4,
AvlNul2, or control infusates. The number of days after infusion on
which the vessels were harvested is indicated. Vessels infused with
AvlLacZ4 (and contralateral control vessels) were harvested at day 10
(n = 6) and day 30 (n = 6). Vessels infused with AvlNul2 (and
contralateral control vessels) were harvested at day 30 (n = 7). The
heights ofthe bars represent mean values calculated from the I/M ratios
of the individual vessels in each group; error bars indicate standard
deviations.
the patterns of staining for ICAM-1, VCAM-1, T cells, and f3-
galactosidase in tissue sections do provide some mechanistic
clues. The differing time courses of expression of ,3-Gal (peak
at 3 d) andICAM-1I/VCAM-1 (maximal at 10-30 d) precluded
staining optimally for both P-Gal and ICAM-1/VCAM-1 ex-
pression in the same arteries. However, staining ofserial frozen
sections taken from three arteries 10 d after gene transfer re-
vealed that ICAM-1 and VCAM-1 expression colocalized with
areas of T cell infiltration far more closely than with areas of
P-Gal expression. In addition, ICAM-1 and VCAM-1 expres-
sion were present in considerably more cells than stained posi-
tively with X-Gal (Fig. 6). While we cannot exclude the pres-
ence of 13-Gal expression at levels too low to detect in those
SMC expressing ICAM-I and VCAM-1 (39), our data suggest
that ICAM-I and VCAM-1 expression are upregulated in SMC
not by direct infection but rather by exposure to T cell-derived
cytokines. In support ofthis hypothesis are reports ofthe upreg-
ulation of ICAM-1 and VCAM-1 by T cell-derived cytokines
such as 1L-4 (40), IL-1, and TNF (34).
Two other mechanisms for the observed upregulation of
SMC ICAM-I and VCAM-1 are: (a) aprimary effect ofadeno-
virus on adhesion molecule expression in infected SMC (as
reported consequent to expression of hepatitis B X protein in
cultured human hepatoma cells [41] or after herpes simplex
virus-i infection ofendothelial cells [42]); (b) upregulation of
cytokine expression in adenovirus-infected SMC with conse-
quent cytokine-induced adhesion molecule expression (similar
to thereported induction ofIL-8 expression by adenovirus infec-
tion of airway epithelial cells in vitro [43]). The preferential
localization of ICAM-1 and VCAM-1 expression to areas of
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IT cell infiltration makes these mechanisms appear less likely.
Moreover, we examined a small number of arteries (3) har-
vested 10 d after infusion with AvlLacZ4 from rabbits treated
with cyclosporine A (15 mg/kg subcutaneously, daily). ,8-Gal
expression in these arteries was at least as high as in arteries
taken from rabbits not treated with cyclosporine A; however,
arterial T cell infiltrates, ICAM-1, and VCAM-1 expression
were noticeably less (data not shown). These data support a
central role for T cell-derived cytokines in the observed vascu-
lar cell activation.
The prominent intramural infiltration of T cells agrees with
previous reports of T cell infiltration in the lungs and livers of
mice exposed to "first generation" adenovirus vectors (i.e.,
vectors in which the El gene is deleted but in which the E2
gene remains intact [16-18]). These T cells are believed to be
cytotoxic T cells, reacting to the expression of low levels of
adenoviral proteins by infiltrating tissues and eliminating trans-
duced cells ( 16). Again, as with ICAM-1 and VCAM-1 expres-
sion, the presence ofthe T cell infiltrate should prompt a reeval-
uation ofthe use ofcurrent adenovirus vectors for both biologi-
cal and therapeutic experiments. Specifically, gene transfer
experiments designed to model, treat, or prevent atherosclerosis
will be complicated by superimposition upon an acute inflam-
matory process. If, as has been written, "at least in part, athero-
sclerosis is a form of immune injury to the arterial wall" (37),
this "immune injury" will be most appropriately studied and
treated in the absence of the acute inflammatory disease that
results from exposure to adenovirus.
Our finding of increased neointima formation was unantici-
pated in light of current attempts to use adenovirus vectors to
prevent arterial proliferative disease (2-4). The stimulus for
neointimal growth that results from adenovirus exposure is not
clear, but could include direct mitogenic effects of the virus or
indirect effects via infiltrating T cells. Of note, T cells can
synthesize factors that stimulate growth of vascular cells and
fibroblasts, including basic fibroblast growth factor and heparin-
binding epidermal growth factor-like growth factor (44, 45).
Our finding of intimal hyperplasia is similar to a recent report
of inflammatory infiltrates, reactive hyperplasia, and squamous
metaplasia in the tracheas of adenoviral vector-infected fetal
lambs (46), and suggests that adenovirus-related tissue remod-
eling is not limited to blood vessels. In addition, this recent
report, as well as previous reports of prolonged (at least 2 mo)
inflammation in the lungs of primates exposed to adenovirus
vectors (47, 48), suggests that the pathogenic effects of adeno-
virus vector exposure that we describe are not limited to rabbits.
Attempts to introduce first generation adenovirus vectors into
the human vasculature should take into account the possibility
that arterial pathology similar to that described herein might be
produced.
Ourresults with UV-inactivated virus indicate that improve-
ments in vector design that decrease virus gene expression may
lessen vascular activation consequent to adenovirus gene trans-
fer. UV-inactivated virus serves as a model offuture generations
of adenovirus vector that may eventually mediate efficient gene
transfer with no viral gene expression. It is notable that although
use ofthe UV-inactivated virus resulted in decreased inflamma-
tion and vascular activation, the intensity of staining for ICAM-
1, VCAM-1, and T cells in arteries infused with UV-inactivated
virus was still above that present in arteries infused with vehicle
only. Our data are in agreement with the recent data of Yang
et al., who infused UV-inactivated adenovirus into mouse lungs
(49), suggesting that the viral protein load itself, in the absence
of virus gene expression, may be sufficient to provoke a host
immune response. Studies with future generations ofadenovirus
vectors (in which virus gene expression is further suppressed
or even eliminated) will need to address this issue of whether
adenovirus-mediated gene delivery can ever be accomplished
with minimal accompanying tissue inflammation.
Our observation of adenovirus-induced neointimal growth
contrasts with reports of the ability of adenovirus vectors ex-
pressing cytotoxic or cytostatic genes to suppress neointimal
formation in balloon-injured rat arteries by 40-50% (2-4).
These findings do not necessarily conflict with those reported
herein. It is possible that in a balloon-injured artery (as opposed
to a minimally injured artery), local growth factor production
is not limiting, and therefore the contribution of adenovirus
infection to neointima formation is not significant. Alterna-
tively, adenovirus-induced neointima formation may moderate
the success of these therapeutic protocols, and if gene transfer
could be accomplished using a vector backbone that had no
primary effects on the arterial wall, the reduction in neointima
formation might approach 100%.
In conclusion, we demonstrate that the ability of adenovirus
vectors to achieve high efficiency in vivo arterial gene transfer
is tempered by the occurrence of vascular cell activation, in-
flammation, and neointimal proliferation in normal rabbit arter-
ies. Efforts at vector development should be directed at min-
imizing these effects so that the potential of adenovirus vectors
to serve as investigational and therapeutic tools in vascular
biology may be realized.
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